Workshop in Dresden: “Biomarkers for Radiation Oncology”
News of April 1
|Struktur eines radioaktiven Moleküls - Im HZDR findet Grundlagenforschung für neue radioaktive Substanzen statt, die in Zukunft in der Krebsmedizin eingesetzt werden können
|Foto: HZDR/Sander Münster
Biomarkers play an important role in the modern clinical treatment of cancer. From May 18 to 20 experts in this field of research will gather in Dresden at the OncoRay – National Center for Radiation Research in Oncology for an international workshop.
The discovery, exploration and validation of biomarkers becomes increasingly important in clinical research and practice in the era of targeted therapy. Identification of the multiple biological parameters that may contribute to the differential response of tumors to radiotherapy drives the concept of individualized therapy.
The aim of this workshop is to bring together the most recent insights and viewpoints on the predictive biomarkers for radiation oncology, from their preclinical development to clinical studies, and to find common ground for future collaborative studies.
OncoRay is jointly operated by the Medical Faculty of the TU Dresden, the University Hospital Carl Gustav Carus and the Helmholtz-Zentrum Dresden-Rossendorf. The objective of the research at OncoRay is to improve cancer treatment through biologically individualized and technologically optimized radiation therapy.
Deadlines for registration and participation:
- abstract submission: till April 20
- registration for the workshop: till May 1
Please check the workshop webpage to register and find more information:
Prof. Dr. Anna Dubrovska
OncoRay - National Center for Radiation Research in Oncology